Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.76 |
| ▸ | MEN1 | O00255 | 2/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.76 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.76 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | PTGES | O14684 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | DLAT | P10515 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL818622 | 1.00 | ALOX5 (0.76) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL819795 | 0.89 | ALOX5 (0.71) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL12327984 | 0.89 | ALOX5 (0.71) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL29888655 | 0.87 | ALOX5 (0.61) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL7897350 | 0.87 | MEN1 (0.74) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL9773779 | 0.86 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL6125220 | 0.86 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL144835 | 0.86 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL6125218 | 0.86 | ALOX5 (1.00) | ALOX5KDM4EMEN1KMT2AAKR1B10 | |
| SCHEMBL316240 | 0.86 | ALOX5 (0.56) | ALOX5KDM4EMEN1KMT2AAKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102053-A1 | FOAM ENHANCING PHOSPHOLIPID EMULSION SYSTEMS | ABSTRAX TECH INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-20260125625-A1 | HOPS ACIDS STABILIZED EMULSIONS | ABSTRAX TECH INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20260123653-A1 | Foam Enhancing Phospholipid Emulsion Systems | ABSTRAX TECH INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20250262262-A1 | a-ACID AND/OR B-ACID BASED COPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | OROTECH NV (BE) | 2025-08-21 | — | — | US | claimed |
| WO-2025079617-A1 | FOOD COMPOSITION AND METHOD FOR PRODUCING SAME | 株式会社Mizkan Holdings | 2025-04-17 | — | — | WO | claimed |
| US-12246095-B2 | Oral dosage forms comprising a hops extract | THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) | 2025-03-11 | — | — | US | claimed |
| WO-2025046278-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS THEREOF | DANSTAR FERMENT AG (CH) | 2025-03-06 | — | — | WO | claimed |
| EP-4514317-A1 | ?-ACID AND/OR SS-ACID BASED COMPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | Orotech NV (BE) | 2025-03-05 | — | — | EP | claimed |
| EP-4263781-B1 | PROCESS FOR PREPARING A HOP EXTRACT AND A LOW ALCOHOLIC BEER COMPRISING THE SAME | HEINEKEN SUPPLY CHAIN BV (NL) | 2025-02-12 | — | — | EP | claimed |
| EP-3443973-B1 | COMPOSITION FOR IMPROVING RECOGNITION FUNCTIONS | KIRIN HOLDINGS KK (JP) | 2025-02-12 | — | — | EP | claimed |
| WO-2004037180-A2 | COMPOSITIONS THAT TREAT OR INHIBIT PATHOLOGICAL CONDITIONS ASSOCIATED WITH INFLAMMATORY RESPONSE | METAPROTEOMICS, LLC (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040086580-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | META PROTEOMICS, LLC | 2004-05-06 | — | — | US | claimed |
| WO-2004026041-A1 | HOP ACIDS AS A REPLACEMENT FOR ANTIBIOTICS IN ANIMAL FEED | JOHN I. HAAS, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| US-20030096027-A1 | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 | METAGENICS, INC. | 2003-05-22 | — | — | US | claimed |
| WO-2003035007-A2 | CURCUMINOID COMPOSITIONS EXHIBITING SYNERGISTIC INHIBITION OF THE EXPRESSION AND/OR ACTIVITY OF CYCLOOXYGENASE-2 | METAPROTEOMICS, LLC (US) | 2003-05-01 | — | — | WO | claimed |
| US-20030008021-A1 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 | ASHNI NATURACEUTICALS, INC. | 2003-01-09 | — | — | US | claimed |
| WO-2003000185-A2 | COMPLEX MIXTURES EXHIBITING SELECTIVE INHIBITION OF CYCLOOXYGENASE-2 | METAPROTEOMICS, LLC (US) | 2003-01-03 | — | — | WO | claimed |
| EP-0677289-B1 | Pharmaceutical composition for treating osteoporosis | HOECHST MARION ROUSSEL LTD (JP) | 1999-01-13 | — | — | EP | claimed |
| US-5604263-A | ADMINISTERING COMPOUNDS EXTRACTED FROM HOPS TO INHIBIT BONE RESORPTION | HOECHST JAPAN LIMITED (JP) | 1997-02-18 | — | — | US | claimed |
| EP-0677289-A2 | Pharmaceutical composition for treating osteoporosis | HOECHST JAPAN LIMITED (JP) | 1995-10-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040086580-A1 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response | HPGDS, TPSB2, TPSG1 | ALOX5 296/4885KDM4E 4291/4885MEN1 3299/4885 |
| US-20260125625-A1 | HOPS ACIDS STABILIZED EMULSIONS | HAO2, NIPSNAP1, AP2S1 | ALOX5 1575/4885KDM4E 4861/4885MEN1 3371/4885 |
| US-20260123653-A1 | Foam Enhancing Phospholipid Emulsion Systems | PHOSPHO1, PLTP, PLIN3 | ALOX5 165/4885KDM4E 1930/4885MEN1 1095/4885 |
| US-20250262262-A1 | a-ACID AND/OR B-ACID BASED COPOSITIONS FROM HUMULUS FOR USE IN A HUMAN AND/OR VETERINARY APPLICATION | CYP8B1, HMBS, HPD | ALOX5 339/4885KDM4E 1425/4885MEN1 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.